Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples